| Product Name | MF | CAS | Details |
|---|
| Enpp-1-IN-17 | C18H24N4O2 | 2289736-54-3 | Details |
| Mcl-1 inhibitor 13 | 2445466-06-6 | Details |
| MEK-IN-6 hydrate | 2845153-35-5 | Details |
| FKBP51F67V-selective antagonist Ligand2 | 1680228-76-5 | Details |
| DSO-5a | 2195411-63-1 | Details |
| FD2056 | 2685870-87-3 | Details |
| SLMP53-2 | C26H22N2O2 | 1826116-38-4 | Details |
| Antibacterial agent 141 | 2930013-56-0 | Details |
| Lp-PLA2-IN-14 | 2756855-66-8 | Details |
| SOS1/KRAS-IN-1 | 2836330-34-6 | Details |
| BDM91514 | 2892824-90-5 | Details |
| SARS-CoV-2-IN-57 | 1265624-68-7 | Details |
| HDAC ligand-1 | C7H8N2O | 34840-28-3 | Details |
| RIP1 kinase inhibitor 5 | C13H17F2NO2 | 2428422-17-5 | Details |
| VMAT2-IN-2 tosylate | C27H36F3NO6S | 2608770-12-1 | Details |
| HIV-1 inhibitor-56 | 2952530-45-7 | Details |
| Antileishmanial agent-16 | 2934738-41-5 | Details |
| IRE1α kinase-IN-9 | 1338933-30-4 | Details |
| SHP2-IN-14 | 2673400-91-2 | Details |
| UPCDC30766 | 2152623-68-0 | Details |
| MmpL3-IN-2 | 2944458-65-3 | Details |
| TLR8 agonist 6 | C19H29N7O2 | 2616605-55-9 | Details |
| URAT1&XO inhibitor 2 | C14H12BrNO3 | 1239488-96-0 | Details |
| Lp-PLA2-IN-16 | C22H17F5N4O3 | 1865780-73-9 | Details |
| AMPA receptor modulator-4 | C11H12ClFN2O2S | 2917551-59-6 | Details |
| RIP1 kinase inhibitor 4 | 2919836-00-1 | Details |
| PCSK9-IN-17 | 2455424-72-1 | Details |
| BBDDL2059 | 2691174-27-1 | Details |
| JAK-IN-30 | 2891469-99-9 | Details |
| Antitubercular agent-39 | 1357796-08-7 | Details |
| Z1078601926 | C14H19FN2O | 1493256-85-1 | Details |
| PCSK9-IN-16 | C16H20N6O2S3 | 2455424-51-6 | Details |
| ATR-IN-24 | C23H26N6O2 | 2370889-43-1 | Details |
| KAT modulator-1 | C20H36O2 | 1314006-43-3 | Details |
| Antiproliferative agent-32 | 2925814-05-5 | Details |
| PROTAC α-synuclein degrader 5 | C39H41N7O10 | 2781922-42-5 | Details |
| Lp-PLA2-IN-12 | 2637485-14-2 | Details |
| RIP1 kinase inhibitor 7 | 2428401-23-2 | Details |
| K-80001 | 242800-40-4 | Details |
| AMPK activator 11 | 2948304-00-3 | Details |
| Anticancer agent 147 | 2241283-11-2 | Details |
| Tau protein aggregation-IN-1 | C17H11BrN2O2 | 916179-45-8 | Details |
| Antileishmanial agent-17 | 2934738-40-4 | Details |
| THRβ receptor agonist-1 | 2403721-00-4 | Details |
| P2X3 antagonist 38 | 2545974-71-6 | Details |
| FGFR-IN-11 | 2658488-68-5 | Details |
| Antiproliferative agent-30 | 2713553-88-7 | Details |
| CDK7-IN-22 | C22H25F3N6 | 2173190-60-6 | Details |
| PI3Kγ inhibitor 7 | 2575863-25-9 | Details |
| RIP1 kinase inhibitor 6 | 2428401-62-9 | Details |
| CXCR4-IN-1 | 2304750-48-7 | Details |
| PIKfyve-IN-2 | 2245319-25-7 | Details |
| PHD2-IN-1 | 2768219-28-7 | Details |
| ALK/EGFR-IN-1 | 2730430-08-5 | Details |
| TLR7/8 agonist 9 | C20H26N6O | 2649170-17-0 | Details |
| Mosnodenvir | 2890688-86-3 | Details |
| URAT1&XO inhibitor 1 | 2669726-78-5 | Details |
| TNF-α-IN-10 | 2247720-56-3 | Details |
| MEK-IN-6 | 2845151-86-0 | Details |
| SOS1-IN-16 | 2930763-85-0 | Details |
| ETAP | 2575731-47-2 | Details |
| Antiproliferative agent-34 | 2910858-34-1 | Details |
| DGKζ-IN-1 | C27H25F3N6O2S | 2660218-70-0 | Details |
| Bromodomain inhibitor-12 | 2010124-06-6 | Details |
| PB131 | 2924425-63-6 | Details |
| Lp-PLA2-IN-13 | 2756855-62-4 | Details |
| JAK-IN-28 | 2445500-22-9 | Details |
| Tubulin polymerization-IN-42 | 2640220-51-3 | Details |
| BChE-IN-17 | 2425632-57-9 | Details |
| HPK1 antagonist-1 | C28H29FN6O2 | 2628489-56-3 | Details |
| Protein kinase inhibitor 5 | C29H31F2N7O | 2278204-94-5 | Details |
| Antileishmanial agent-15 | 2934738-38-0 | Details |
| IRE1α kinase-IN-8 | 1338933-29-1 | Details |
| Antifungal agent 59 | 2422019-96-1 | Details |
| Antitumor agent-101 | 2848632-52-8 | Details |
| PAD4-IN-2 | 2642327-52-2 | Details |
| MAT2A-IN-12 | C20H17NO3 | 631897-75-1 | Details |
| IRAK4-IN-28 | 2952532-92-0 | Details |
| A1/A3 AR antagonist 3 | C22H19N5O3 | 2665804-57-7 | Details |
| RET-IN-23 | C28H28FN11 | 2479961-46-9 | Details |
| SSI-4 | C19H21ClN4O3 | 1875084-68-6 | Details |
| ROCK-IN-6 | C19H19N5O8S | 2489328-74-5 | Details |
| DRI-C21041 | C30H21N3O7S | 2101765-78-8 | Details |
| IPG7236 | C23H31N3O3S | 2756350-91-9 | Details |
| Tegeprotafib | C13H11FN2O5S | 2407610-46-0 | Details |
| BET-IN-15 | C21H18F2N4O3S | 2408994-22-7 | Details |
| Bromodomain inhibitor-12 (edisylate) | 2010124-27-1 | Details |
| SORT-PGRN interaction inhibitor 3 | C15H19Cl2NO3 | 2691846-87-2 | Details |
| Lp-PLA2-IN-15 | C22H17F5N4O3 | 1865796-11-7 | Details |
| SUCNR1-IN-1 | 2711753-52-3 | Details |
| STAT6-IN-3 | C32H35IN3O7P | 371919-80-1 | Details |
| ALK2-IN-5 | C24H32N8O2 | 2414149-20-3 | Details |
| DRI-C25441 | C31H21N3O6 | 2101765-83-5 | Details |
| MDM2/XIAP-IN-2 | C29H32N2O4S | 2761969-85-9 | Details |
| TLR7/8 agonist 8 | C24H30N6O | 2649170-16-9 | Details |
| Bivamelagon hydrochloride | C35H54Cl2N4O4 | 2641595-55-1 | Details |
| TRK-IN-23 | 2924344-29-4 | Details |
| S-Gem | C13H15F2N3O6S2 | 2169925-98-6 | Details |
| Bivamelagon | C35H53ClN4O4 | 2641595-54-0 | Details |
| Product Total： Product Page： | ||||
| 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | ||||